Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy?

Filippo Lococo,Marco Chiappetta, Corolina Sassorossi,Dania Nachira,Jessica Evangelista,Leonardo Petracca Ciavarella,Maria Teresa Congedo,Venanzio Porziella,Luca Boldrini, Annarila Larici,Emilio Bria,Stefano Margaritora

Reviews on recent clinical trials（2022）

引用 2|浏览0

暂无评分

摘要

We herein observed suboptimal long-term results in this NSCLC patient subset, and, considering emerging results adopting immunotherapy following chemoradiotherapy, surgery should be carefully considered in very selected cases (young and clinically fit patients) and combined with adjuvant therapy after surgery.

查看译文

关键词

Neoadjuvant therapy,chemotherapy,lung cancer,lymph nodes,radiotherapy,surgery

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要